Skip to content

The Influence of Menopausal Status on Myocardial Stiffness and Exercise Capacity Among Female Masters Endurance Athletes.

The Influence of Menopausal Status on Myocardial Stiffness and Exercise Capacity Among Female Masters Endurance Athletes.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06475768
Enrollment
48
Registered
2024-06-26
Start date
2024-09-14
Completion date
2025-10-06
Last updated
2025-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Stiffness

Brief summary

The purpose of this research is to study postmenopausal female masters athletes to see if they will show greater myocardial stiffness and reduced exercise capacity than premenopausal females and similarly aged male masters athletes.

Interventions

DIAGNOSTIC_TESTStress Echocardiogram

Exercise testing via treadmill with simultaneous gas exchange analysis and pre- and post-exercise transthoracic echocardiography.

DIAGNOSTIC_TESTCardiovascular Magnetic Imaging (cMRI)

Non-invasive imaging scan used to examine function and structure of the heart

DIAGNOSTIC_TESTCardiac Magnetic Resonance Elastography (cMRE)

Non-invasive imaging scan used to measure myocardial stiffness

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Longstanding history of competitive endurance athletic performance defined as \>15 years of continuous athletic training for at least 7 hours per week and ongoing engagement in competitive events.

Exclusion criteria

* A current or prior diagnosis of cardiovascular disease as defined by the presence of structural heart disease, heart failure, symptomatic coronary artery disease, more than moderate valve disease or prior valve surgery, * Current or recent pregnancy within 1 year * Positive pregnancy test (study visit 1) * Concurrent or use within 1 year of oral contraceptives or hormone replacement therapy, * Unable to undergo a cMRI (Please refer standard clinical contraindications for MRI)

Design outcomes

Primary

MeasureTime frameDescription
Myocardial stiffnessDay 14Myocardial stiffness will be measured by magnetic resonance elastography (kPa)

Secondary

MeasureTime frameDescription
Left ventricular filling pressures with exerciseBaselineLeft ventricular filling pressures with exercise will be measured by stress echocardiography
Exercise capacityBaselineExercise capacity will be measured by stress echocardiography

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026